Balanites aegyptiaca ameliorates insulin secretion and decreases pancreatic apoptosis in diabetic rats

rle of SAPK/JNK pathway

Kamel M.A. Hassanin, Mohamed O. Mahmoud, Hossam M. Hassan, Abdel-Razik H. Abdel-Razik, Lourin N. Aziz, Mostafa E. Rateb

Research output: Contribution to journalArticle

50 Downloads (Pure)

Abstract

SAPK-JNK pathway performs a significant role in the pathogenesis of type 2 diabetes. Balanites aegyptiaca (BA) is used as an anti-diabetic agent in folk medicine however its hypoglycemic mechanism is not fully elucidated. The current study aimed to evaluate the effect of crude extract, butanol, and dichloromethane fractions from BA on the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK-JNK) pathway in experimental diabetic rats. Six groups of male Wistar rats were included: normal control, diabetic, diabetic rats treated with crude, butanol or dichloromethane fraction from BA (50 mg/kg BW) and diabetic rats treated with gliclazide as a reference drug for one month. Our results suggested a protective role of treatment of diabetic rats with BA against oxidative stress-induced SAPK-JNK pathway. Moreover, BA treatment produced a reduction in plasma glucose, HbA1c, lactic acid, lipid profile, malondialdehyde levels and produced an increase in insulin, reduced glutathione levels, catalase and superoxide dismutase activities compared with untreated diabetic rats. Moreover, it decreased apoptosis signal-regulating kinase 1, c-Jun N-terminal kinase 1, protein 53 and increased insulin receptor substrate 1 in rat pancreas while it increased glucose transporter 4 in rat muscle. Analysis of BA extracts by LC-HRMS revealed the presence of different saponins with reported hypoglycemic effect. In conclusion, BA exerted hypoglycemic, hypolipidemic, insulinotropic and antioxidant effects. Additionally, it reduced apoptosis in pancreatic β-cells and increased glucose uptake in muscle. These results suggest that the hypoglycemic effect of BA is due to the inhibition of the SAPK-JNK pathway.

Original languageEnglish
Pages (from-to)1084 - 1091
JournalBiomedicine & Pharmacotherapy
Volume102
Early online date5 Apr 2018
DOIs
Publication statusPublished - 1 Jun 2018

Fingerprint

Balanites
MAP Kinase Signaling System
Insulin
Apoptosis
JNK Mitogen-Activated Protein Kinases
Heat-Shock Proteins
Hypoglycemic Agents
Protein Kinases
Butanols
Methylene Chloride
MAP Kinase Kinase Kinase 5
Mitogen-Activated Protein Kinase 8
Gliclazide
Insulin Receptor Substrate Proteins
Glucose
Muscles
Facilitative Glucose Transport Proteins
Saponins
Traditional Medicine
Malondialdehyde

Keywords

  • Diabetes
  • Apoptosis
  • Oxidative stress
  • SAPK-JNK pathway

Cite this

Hassanin, Kamel M.A. ; Mahmoud, Mohamed O. ; Hassan, Hossam M. ; Abdel-Razik, Abdel-Razik H. ; Aziz, Lourin N. ; Rateb, Mostafa E. / Balanites aegyptiaca ameliorates insulin secretion and decreases pancreatic apoptosis in diabetic rats : rle of SAPK/JNK pathway. In: Biomedicine & Pharmacotherapy. 2018 ; Vol. 102. pp. 1084 - 1091.
@article{14d301da68564814947a2e90a23d2bc4,
title = "Balanites aegyptiaca ameliorates insulin secretion and decreases pancreatic apoptosis in diabetic rats: rle of SAPK/JNK pathway",
abstract = "SAPK-JNK pathway performs a significant role in the pathogenesis of type 2 diabetes. Balanites aegyptiaca (BA) is used as an anti-diabetic agent in folk medicine however its hypoglycemic mechanism is not fully elucidated. The current study aimed to evaluate the effect of crude extract, butanol, and dichloromethane fractions from BA on the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK-JNK) pathway in experimental diabetic rats. Six groups of male Wistar rats were included: normal control, diabetic, diabetic rats treated with crude, butanol or dichloromethane fraction from BA (50 mg/kg BW) and diabetic rats treated with gliclazide as a reference drug for one month. Our results suggested a protective role of treatment of diabetic rats with BA against oxidative stress-induced SAPK-JNK pathway. Moreover, BA treatment produced a reduction in plasma glucose, HbA1c, lactic acid, lipid profile, malondialdehyde levels and produced an increase in insulin, reduced glutathione levels, catalase and superoxide dismutase activities compared with untreated diabetic rats. Moreover, it decreased apoptosis signal-regulating kinase 1, c-Jun N-terminal kinase 1, protein 53 and increased insulin receptor substrate 1 in rat pancreas while it increased glucose transporter 4 in rat muscle. Analysis of BA extracts by LC-HRMS revealed the presence of different saponins with reported hypoglycemic effect. In conclusion, BA exerted hypoglycemic, hypolipidemic, insulinotropic and antioxidant effects. Additionally, it reduced apoptosis in pancreatic β-cells and increased glucose uptake in muscle. These results suggest that the hypoglycemic effect of BA is due to the inhibition of the SAPK-JNK pathway.",
keywords = "Diabetes, Apoptosis, Oxidative stress, SAPK-JNK pathway",
author = "Hassanin, {Kamel M.A.} and Mahmoud, {Mohamed O.} and Hassan, {Hossam M.} and Abdel-Razik, {Abdel-Razik H.} and Aziz, {Lourin N.} and Rateb, {Mostafa E.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.biopha.2018.03.167",
language = "English",
volume = "102",
pages = "1084 -- 1091",
journal = "Biomedicine & Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier B.V.",

}

Balanites aegyptiaca ameliorates insulin secretion and decreases pancreatic apoptosis in diabetic rats : rle of SAPK/JNK pathway. / Hassanin, Kamel M.A.; Mahmoud, Mohamed O.; Hassan, Hossam M.; Abdel-Razik, Abdel-Razik H.; Aziz, Lourin N.; Rateb, Mostafa E.

In: Biomedicine & Pharmacotherapy, Vol. 102, 01.06.2018, p. 1084 - 1091.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Balanites aegyptiaca ameliorates insulin secretion and decreases pancreatic apoptosis in diabetic rats

T2 - rle of SAPK/JNK pathway

AU - Hassanin, Kamel M.A.

AU - Mahmoud, Mohamed O.

AU - Hassan, Hossam M.

AU - Abdel-Razik, Abdel-Razik H.

AU - Aziz, Lourin N.

AU - Rateb, Mostafa E.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - SAPK-JNK pathway performs a significant role in the pathogenesis of type 2 diabetes. Balanites aegyptiaca (BA) is used as an anti-diabetic agent in folk medicine however its hypoglycemic mechanism is not fully elucidated. The current study aimed to evaluate the effect of crude extract, butanol, and dichloromethane fractions from BA on the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK-JNK) pathway in experimental diabetic rats. Six groups of male Wistar rats were included: normal control, diabetic, diabetic rats treated with crude, butanol or dichloromethane fraction from BA (50 mg/kg BW) and diabetic rats treated with gliclazide as a reference drug for one month. Our results suggested a protective role of treatment of diabetic rats with BA against oxidative stress-induced SAPK-JNK pathway. Moreover, BA treatment produced a reduction in plasma glucose, HbA1c, lactic acid, lipid profile, malondialdehyde levels and produced an increase in insulin, reduced glutathione levels, catalase and superoxide dismutase activities compared with untreated diabetic rats. Moreover, it decreased apoptosis signal-regulating kinase 1, c-Jun N-terminal kinase 1, protein 53 and increased insulin receptor substrate 1 in rat pancreas while it increased glucose transporter 4 in rat muscle. Analysis of BA extracts by LC-HRMS revealed the presence of different saponins with reported hypoglycemic effect. In conclusion, BA exerted hypoglycemic, hypolipidemic, insulinotropic and antioxidant effects. Additionally, it reduced apoptosis in pancreatic β-cells and increased glucose uptake in muscle. These results suggest that the hypoglycemic effect of BA is due to the inhibition of the SAPK-JNK pathway.

AB - SAPK-JNK pathway performs a significant role in the pathogenesis of type 2 diabetes. Balanites aegyptiaca (BA) is used as an anti-diabetic agent in folk medicine however its hypoglycemic mechanism is not fully elucidated. The current study aimed to evaluate the effect of crude extract, butanol, and dichloromethane fractions from BA on the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK-JNK) pathway in experimental diabetic rats. Six groups of male Wistar rats were included: normal control, diabetic, diabetic rats treated with crude, butanol or dichloromethane fraction from BA (50 mg/kg BW) and diabetic rats treated with gliclazide as a reference drug for one month. Our results suggested a protective role of treatment of diabetic rats with BA against oxidative stress-induced SAPK-JNK pathway. Moreover, BA treatment produced a reduction in plasma glucose, HbA1c, lactic acid, lipid profile, malondialdehyde levels and produced an increase in insulin, reduced glutathione levels, catalase and superoxide dismutase activities compared with untreated diabetic rats. Moreover, it decreased apoptosis signal-regulating kinase 1, c-Jun N-terminal kinase 1, protein 53 and increased insulin receptor substrate 1 in rat pancreas while it increased glucose transporter 4 in rat muscle. Analysis of BA extracts by LC-HRMS revealed the presence of different saponins with reported hypoglycemic effect. In conclusion, BA exerted hypoglycemic, hypolipidemic, insulinotropic and antioxidant effects. Additionally, it reduced apoptosis in pancreatic β-cells and increased glucose uptake in muscle. These results suggest that the hypoglycemic effect of BA is due to the inhibition of the SAPK-JNK pathway.

KW - Diabetes

KW - Apoptosis

KW - Oxidative stress

KW - SAPK-JNK pathway

U2 - 10.1016/j.biopha.2018.03.167

DO - 10.1016/j.biopha.2018.03.167

M3 - Article

VL - 102

SP - 1084

EP - 1091

JO - Biomedicine & Pharmacotherapy

JF - Biomedicine & Pharmacotherapy

SN - 0753-3322

ER -